Kim Berentsen
Synthon (Netherlands)(NL)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Epigenetics and DNA Methylation, Cholinesterase and Neurodegenerative Diseases, bioluminescence and chemiluminescence research, Acute Myeloid Leukemia Research
Most-Cited Works
- → Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity(2014)1,657 cited
- → The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease(2016)1,397 cited
- → Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells(2016)771 cited
- → Dynamics of Transcription Regulation in Human Bone Marrow Myeloid Differentiation to Mature Blood Neutrophils(2018)134 cited
- → Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration(2016)113 cited
- → The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs(2016)71 cited
- → Chromatin-Based Classification of Genetically Heterogeneous AMLs into Two Distinct Subtypes with Diverse Stemness Phenotypes(2019)65 cited
- → Unraveling the Interaction between Carboxylesterase 1c and the Antibody–Drug Conjugate SYD985: Improved Translational PK/PD by Using Ces1c Knockout Mice(2018)49 cited
- → Multi-omics profiling reveals a distinctive epigenome signature for high-risk acute promyelocytic leukemia(2018)14 cited
- → Abstract 925: Introduction to the preclinical profile of SYD1875, a novel site-specifically conjugated duocarmycin-based 5T4-targeting antibody-drug conjugate(2021)5 cited